单次超声引导胸椎旁阻滞与腹横肌平面阻滞在腹膜透析导管置入术中的随机对照试验比较
结果显示TAP组在多数时间点VAS较低,但TPVB组在导管出口处VAS更低;TAP组转全麻率更低、舒芬太尼追加量更少、满意度更高。结论:单次US-TPVB在导管出口处镇痛更优,但整体麻醉质量与LAI相当,不及TAP。
要点
- TAP阻滞在腹膜透析导管置入术中多数时间点镇痛优于TPVB。
- TPVB在导管出口处镇痛效果优于TAP和LAI。
- TAP组转全麻率更低、舒芬太尼用量更少、满意度更高。
核心结论
- 单次US-TPVB在导管出口处提供更好的镇痛,但整体麻醉质量和可靠性不如斜行肋下TAP阻滞,与LAI相当。
研究设计与样本
- TPVB组在T10-T11水平行单次超声引导胸椎旁阻滞,使用20 ml 0.25%罗哌卡因。
- TAP组行斜行肋下腹横肌平面阻滞,使用20 ml 0.25%罗哌卡因。
- LAI组使用40 ml 0.25%罗哌卡因局部浸润。
主要发现
- 除导管出口处外,多数时间点TAP组VAS低于TPVB组。
- 壁层腹膜操作时VAS:TPVB组6(5,7),TAP组3(0,6),LAI组7(4.75,9),P<0.001。
- 导管出口处VAS:TPVB组4(3,4),TAP组5.5(4,8),LAI组5(3,7.25),P=0.005。
- TAP组转全麻率更低、累积追加舒芬太尼用量更少、肾内科医生和患者满意度更高。
临床怎么用
- 对于腹膜透析导管置入术,斜行肋下TAP阻滞可作为首选麻醉方式,因其整体麻醉质量更优。
- 若需重点改善导管出口处镇痛,可考虑单次US-TPVB,但需权衡其整体麻醉质量不及TAP。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous study indicated that transversus abdominis plane (TAP) block could be the principal anesthetic technique for peritoneal dialysis catheter (PDC) implantations. However, a TAP block could not provide an optimal anesthetic effect on catheter exit site during PDC implantation. We hypothesized that single-injection ultrasound-guided thoracic paravertebral block (US-TPVB) could be the principal anesthetic technique with better pain relief at catheter exit site during PDC implantation, compared to a TAP block. And anesthesia quality of a single-injection US-TPVB was compared with that of a TAP block and local anesthetic infiltration (LAI). METHODS: Patients undergoing PDC implantations were randomized into groups TPVB or TAP or LAI. In group TPVB, single-injection US-TPVB at T10-T11 level was performed with 20 ml of 0.25% ropivacaine. In group TAP, oblique subcostal TAP block was performed with 20 ml of 0.25% ropivacaine. In group LAI, 40 ml of 0.25% ropivacaine was used. Anesthesia quality was compared among the three groups, including general anesthesia conversion rate, cumulative rescuing sufentanil consumption, and satisfaction rate by nephrologists and patients. RESULTS: Eighty-eight eligible patients were enrolled. Visual analogue scale (VAS) at most time points (except for the catheter exit site) were lower in group TAP, compared with group TPVB. VAS at parietal peritoneum manipulation was 6 (5, 7), 3 (0, 6), and 7 (4.75, 9) in groups TPVB, TAP, and LAI, respectively (P < 0.001). VAS at catheter exit site was 4 (3, 4), 5.5 (4, 8), and 5 (3, 7.25) in groups TPVB, TAP, and LAI, respectively (P = 0.005). Lower general anesthesia conversion rate, less cumulative rescuing sufentanil consumption, and higher satisfaction rates by nephrologists and patients were recorded in group TAP, compared with groups TPVB and LAI. CONCLUSIONS: Single-injection US-TPVB provided a better pain relief at catheter exit site. The quality and reliability of anesthesia after a single-injection US-TPVB was comparable to that of LAI, but not better than that of an oblique subcostal TAP block for PDC implantation. TRIAL REGISTRATION: TCTR20160911002 . Registered on 8 September 2016.
引用
- Jiang XJ, Li Z, Li Q, et al. Comparison of single-injection ultrasound-guided thoracic paravertebral block with transversus abdominis plane block in peritoneal dialysis catheter implantation: a randomized controlled trial. Trials. 2021. PMID: 33836814. doi:10.1186/s13063-021-05223-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。